Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BCL6, MUM1, and CD10 expression in mantle cell lymphoma.

Applied immunohistochemistry & molecular morphology : AIMM - 1 Mar 2010

Gualco Gabriela, Weiss Lawrence M, Harrington William J, Bacchi Carlos E

Abstract excerpt

Mantle cell lymphoma (MCL) characteristically express CD20, CD5, and cyclin-D1, carries the translocation t(11;14) (q13;q32) and typically has no expression of germinal center cell markers. So-called aberrant phenotypes such as CD5 negative and cyclin-D1-negative MCL have been described. Also few cases with CD10 and/or BCL-6 protein expression have been reported. We analyzed 127 MCL looking for the frequency of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD5 Antigens
Share to Cyclin D
Share to Gene Expression Regulation, Leukemic

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Germinal Center

Share to Lymphoma, Mantle-Cell

Share to Neprilysin

Share to Oncogene Proteins, Fusion

Share to Proto-Oncogene Proteins c-bcl-6

Source

Open in PubMed Open full text

Identifiers

PMID: 19826251
DOI: 10.1097/PAI.0b013e3181bb9edf
PMCID: PMC2828511

Genes

BCL6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BCL6, MUM1, and CD10 expression in mantle cell lymphoma.PMID 19826251Read ↗

Aberrant expression of CD 10 and BCL 6 in mantle cell lymphomaSemantic proximity Read ↗

Mantle cell lymphoma with aberrant expression of CD10Semantic proximity Read ↗

CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.Semantic proximity Read ↗

CD5– Mantle Cell LymphomaSemantic proximity Read ↗

Mantle cell lymphoma pathology update in the 2016 WHO classificationSemantic proximity Read ↗

Leukemic Variant of Mantle Cell Lymphoma: Clinical Presentation and Management.Semantic proximity Read ↗

CD10-positive mantle cell lymphoma: biologically distinct entity or an aberrant immunophenotype? Insight, through gene expression profile in a unique case series.Semantic proximity Read ↗

Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangementsSemantic proximity Read ↗

Mantle cell lymphoma with chronic lymphocytic leukemia-like features: a diagnostic mimic and pitfall.Semantic proximity Read ↗

Molecular Pathogenesis of Mantle Cell Lymphoma.Semantic proximity Read ↗

Identification of CD5/Cyclin D1 Double-negative Pleomorphic Mantle Cell Lymphoma: A Clinicopathologic, Genetic, and Gene Expression Study.Semantic proximity Read ↗

CD200 expression in mantle cell lymphoma identifies a unique subgroup of patients with frequent IGHV mutations, absence of SOX11 expression, and an indolent clinical course.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.